Drug Profile
Research programme: calcium channel and sodium channel antagonists - Anabios Corporation
Alternative Names: N-type CCB; N/T-Type CCB; NP-A; T-type CCB; Z-212Latest Information Update: 28 Jul 2016
Price :
$50
*
At a glance
- Originator Neuromed Pharmaceuticals
- Developer Hydra Biosciences; Neuromed Pharmaceuticals
- Class Analgesics; Small molecules
- Mechanism of Action N type calcium channel antagonists; Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Pain